Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew A Spinelli

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Open Forum Infectious Diseases|June 4, 2025
Feasibility of Point-of-Care Urine Self-Testing to Measure Tenofovir Adherence and Predict Viral SuppressionRenata Buccheri, Matthew A Spinelli, Megan J Heise, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2020
Use of Drug-level Testing and Single-genome Sequencing to Unravel a Case of Human Immunodeficiency Virus Seroconversion on Pre-exposure ProphylaxisMatthew A Spinelli, Brentton Lowery, Jennifer A Shuford, et al.
AIDS (London, England)|June 21, 2024
Point-of-care urine tenofovir test predicts future HIV preexposure prophylaxis discontinuation among young usersTyler Martinson, Rikki Montoya, Carlos Moreira, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 8, 2024
Prevalence and Correlates of SARS-CoV-2 Vaccine Uptake and Hesitancy Among People With HIV Across the United StatesMatthew A Spinelli, Mallory O Johnson, Nadra E Lisha, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2023
Viral Suppression Trajectories Destabilized After Coronavirus Disease 2019 Among US People With Human Immunodeficiency Virus: An Interrupted Time Series AnalysisMatthew A Spinelli, Katerina A Christopoulos, Carlos V Moreira, et al.
Open Forum Infectious Diseases|September 10, 2024
Impact of the Coronavirus Disease 2019 Pandemic on Substance Use Disorder Risk Among People Living With Human Immunodeficiency Virus (HIV) Enrolled in HIV Care in the United States: An Interrupted Time Series AnalysisJennifer P Jain, Megan J Heise, Nadra E Lisha, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Plasma-based antigen persistence in the post-acute phase of SARS-CoV-2 infectionMichael J Peluso, Zoe N Swank, Sarah A Goldberg, et al.
The Lancet. Infectious Diseases|April 11, 2024
Plasma-based antigen persistence in the post-acute phase of COVID-19Michael J Peluso, Zoe N Swank, Sarah A Goldberg, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19Michael J Peluso, Amelia N Deitchman, Leonel Torres, et al.
Cell Reports|August 6, 2021
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptomsMichael J Peluso, Amelia N Deitchman, Leonel Torres, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Open Forum Infectious Diseases|June 4, 2025
Feasibility of Point-of-Care Urine Self-Testing to Measure Tenofovir Adherence and Predict Viral SuppressionRenata Buccheri, Matthew A Spinelli, Megan J Heise, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2020
Use of Drug-level Testing and Single-genome Sequencing to Unravel a Case of Human Immunodeficiency Virus Seroconversion on Pre-exposure ProphylaxisMatthew A Spinelli, Brentton Lowery, Jennifer A Shuford, et al.
AIDS (London, England)|June 21, 2024
Point-of-care urine tenofovir test predicts future HIV preexposure prophylaxis discontinuation among young usersTyler Martinson, Rikki Montoya, Carlos Moreira, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 8, 2024
Prevalence and Correlates of SARS-CoV-2 Vaccine Uptake and Hesitancy Among People With HIV Across the United StatesMatthew A Spinelli, Mallory O Johnson, Nadra E Lisha, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2023
Viral Suppression Trajectories Destabilized After Coronavirus Disease 2019 Among US People With Human Immunodeficiency Virus: An Interrupted Time Series AnalysisMatthew A Spinelli, Katerina A Christopoulos, Carlos V Moreira, et al.
Open Forum Infectious Diseases|September 10, 2024
Impact of the Coronavirus Disease 2019 Pandemic on Substance Use Disorder Risk Among People Living With Human Immunodeficiency Virus (HIV) Enrolled in HIV Care in the United States: An Interrupted Time Series AnalysisJennifer P Jain, Megan J Heise, Nadra E Lisha, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Plasma-based antigen persistence in the post-acute phase of SARS-CoV-2 infectionMichael J Peluso, Zoe N Swank, Sarah A Goldberg, et al.
The Lancet. Infectious Diseases|April 11, 2024
Plasma-based antigen persistence in the post-acute phase of COVID-19Michael J Peluso, Zoe N Swank, Sarah A Goldberg, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19Michael J Peluso, Amelia N Deitchman, Leonel Torres, et al.
Cell Reports|August 6, 2021
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptomsMichael J Peluso, Amelia N Deitchman, Leonel Torres, et al.
Pageof 8